Good morning. It’s Monday, Jul 14. Today we are covering:
Microsoft will halt new Office features for Windows 10 in 2026
Alibaba-backed Moonshot releases new Kimi AI model that beats ChatGPT, Claude in coding - and it costs less
China Biotech's Stunning Advance Is Changing the World's Drug Pipeline
Where are the iPhone's WebKit-less browsers?
Why the U.S. Is Way Behind China in Making Drones for War
Let’s dive in
Microsoft will halt new Office features for Windows 10 in 2026
By Tom Warren via The Verge
Microsoft will stop adding new features to Microsoft 365 apps on Windows 10 starting August 2026, affecting both personal and business users across all update channels by January 2027.
Security updates for Office apps on Windows 10 will continue until October 10, 2028, even after Windows 10 reaches end-of-life on October 14, 2025.
The move is part of Microsoft’s broader push to migrate users to Windows 11, which is now the most widely used desktop OS, with incentives like free extended security support for users who enable Windows Backup.
𝕏: Microsoft will halt new Office features for Windows 10 in 2026. You’ll have to upgrade to Windows 11 if you want the latest Microsoft 365 app improvements. - Tom Warren (@tomwarren)
By Evelyn Cheng via CNBC
Alibaba-backed Moonshot has released Kimi K2, a low-cost, open-source AI model focused on coding, claiming it outperforms Claude Opus 4 and GPT-4.1 on multiple industry benchmarks.
Kimi K2 undercuts competitors on pricing, charging just $0.15 per million input tokens and $2.50 per million output tokens, compared to GPT-4.1’s $2/$8 and Claude’s $15/$75 rates.
The model’s release coincides with OpenAI’s indefinite delay of its first open-source model and rising investor interest in Chinese AI alternatives, with Kimi K2 drawing early praise for its production-ready performance and advanced coding capabilities.
𝕏: In case you still not catching up this… Moonshot had quite decent models even back to couple months ago during "DeepSeek frenzy" - Ray Wang (@rwang07)
The best way to reach new readers is through word of mouth. If you click THIS LINK in your inbox, it’ll create an easy-to-send pre-written email you can just fire off to some friends.
China Biotech's Stunning Advance Is Changing the World's Drug Pipeline
By Amber Tong via Bloomberg
Chinese biotech firms are rapidly closing the innovation gap with the US, developing over 1,250 novel drugs in 2024—surpassing the EU and nearing America’s 1,440.
Once seen as copycats, China’s drugmakers are now a driving force in global biotech, advancing treatments in areas like cancer and weight loss.
This surge mirrors China’s momentum in AI and EVs, signaling a broader push to challenge Western dominance in cutting-edge industries.
𝕏: “A key advantage that has fueled the rise of Chinese biotech firms is their ability to conduct research cheaper and faster at every step of the way, from lab experiments and animal testing to human trials.” Big Bloomberg piece on China’s biotech industry - Kyle Chan (@kyleichan)
Where are the iPhone's WebKit-less browsers?
By Jess Weatherbed via The Verge
Apple’s technical and legal barriers—including restrictive terms, lack of testing tools, and the requirement to build entirely new apps—have deterred major developers like Google and Mozilla from launching non-WebKit browsers on iOS, despite new EU rules.
The Open Web Advocacy (OWA) accuses Apple of noncompliance with the DMA, arguing that the company’s policies stifle competition and protect Safari’s lucrative revenue stream, estimated at $20 billion annually from Google search deals.
Regulators outside the EU, including in the UK, are also pressuring Apple to ease restrictions, citing its and Google’s role in hindering mobile browser innovation.
Why the U.S. Is Way Behind China in Making Drones for War
By Farah Stockman via The New York Times
The U.S. military is struggling to match China’s dominance in drone production, with tests in Alaska exposing technical failures, outdated countermeasures, and a lack of operational readiness compared to adversaries like Russia and China.
Bureaucratic hurdles and reliance on expensive legacy systems have left the U.S. trailing behind in fielding cheap, adaptable drones, while Chinese firm DJI accounts for around 70% of global commercial drone sales, dwarfing American output.
Startups like Neros and Dragoon are trying to fill the gap with U.S.-made drones, but domestic manufacturers still face scale, funding, and technological limitations, as highlighted by Defense Secretary Pete Hegseth and efforts like the “Unleashing American Drone Dominance” executive order.
We're thrilled to bring you ad-free news. To keep it that way, we need your support. Your pledge helps us stay independent and deliver high-quality insights while exploring new ideas. What would you love to see next? Share your thoughts and help shape the future of Newslit Daily. Thank you for being part of this journey!
Trending in AI
California is set to become the first US state to manage power outages with AI
Nvidia’s Huang Says China’s Military Unlikely to Use US AI Chips
Vast Numbers of Lonely Kids Are Using AI as Substitute Friends
Malaysia Controls AI Chip Exports as US Targets China Smuggling
Thanks for reading to the bottom and soaking in our Newslit Daily fueled with highlights for your morning.
I hope you found it interesting and, needless to say, if you have any questions or feedback let me know by hitting reply.
Take care and see you tomorrow!
How was today’s email?
Share this post